Antiviral medication to reduce symptoms of COVID-19: A phase 3, placebo-controlled trial

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: COVID-19
  • Age: Between 18 - 64 Years
  • Gender: Male or Female

Recruitment Status


Check to see if you pre-qualify for the study.

Are you between the age of 18 and 64?
Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a non-cancer study or if you have any questions, please email